Erin Garcia de Jesús is a staff writer at Science News. She holds a Ph.D. in microbiology from the University of Washington, where she studied virus/host co-evolution. After deciding science as a whole was too fascinating to spend a career studying one topic, she went on to earn a master’s in science communication from the University of California, Santa Cruz. Her writing has appeared in Nature News, Science, Eos, Smithsonian Voices and more, and she was the winter 2019 science writing intern at Science News.
Trustworthy journalism comes at a price.
Scientists and journalists share a core belief in questioning, observing and verifying to reach the truth. Science News reports on crucial research and discovery across science disciplines. We need your financial support to make it happen – every contribution makes a difference.
All Stories by Erin Garcia de Jesús
-
Health & Medicine
50 years ago, oxygen was touted as a potential memory loss treatment
In 1972, researchers were studying whether hyperbaric chambers could help reverse senility. Today, science is still piecing together clues.
-
Health & Medicine
How to interpret the CDC’s new mask guidelines
Based on the CDC’s new metrics, most people no longer need to wear masks in most situations, but that could change.
-
Microbes
A chain mail–like armor may shield C. difficile from some antibiotics
Examining the structures that protect Clostridioides difficile from medicines could help researchers find new ways to target and kill the bacteria.
-
Health & Medicine
The COVID-19 pandemic is not an on-off switch
The pandemic is more of a dimmer switch, and it will be a slow slide to the endemic phase, says epidemiologist Aubree Gordon.
-
Genetics
Gene therapies for sickle cell disease come with hope and challenges
Pediatrician Erica Esrick discusses existing sickle cell treatments and an ongoing clinical trial.
-
Health & Medicine
Omicron crushed delta in the U.S. These numbers show just how fast it happened
It took the delta coronavirus variant eight weeks to make up more than 50 percent of new U.S. COVID-19 infections, estimates show. It took omicron two.
-
Genetics
How one scientist aims to boost Black people’s representation in genetic datasets
Through information sharing, geneticist Tshaka Cunningham wants to build trust and encourage more Black people to engage with the medical community.
-
Health & Medicine
Genetically engineered immune cells have kept two people cancer-free for a decade
Long-lasting leukemia remission prompts doctors to call CAR-T cell therapy a ‘cure’ for some.
-
Animals
Gut microbes help some squirrels stay strong during hibernation
Microbes living in the critters’ guts take nitrogen from urea and put it into the amino acid glutamine, helping squirrels retain muscle in the winter.
-
Humans
Babies may use saliva sharing to figure out relationships
Actions like sharing bites of food or kissing may cue young children into close bonds, a new study suggests.
-
Genetics
A genetic analysis hints at why COVID-19 can mess with smell
People with some genetic variants close to smell-related genes had an 11 percent higher risk of losing their sense of taste or smell.
-
Health & Medicine
The omicron variant is surging. Here’s what we’ve learned so far
Omicron is better at evading virus-attacking antibodies than previous coronavirus variants, but there are signs booster shots might help curb symptoms.